Insider Transactions in Q1 2025 at Krystal Biotech, Inc. (KRYS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2025
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.32%
|
$4,425,000
$177.72 P/Share
|
|
Mar 13
2025
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.34%
|
$4,425,000
$177.76 P/Share
|
|
Mar 13
2025
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.34%
|
$4,425,000
$177.76 P/Share
|
|
Mar 13
2025
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.32%
|
$4,425,000
$177.72 P/Share
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
21,985
-0.47%
|
$3,935,315
$179.25 P/Share
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Indirect |
47,500
+1.0%
|
-
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
13,885
-0.46%
|
$2,485,415
$179.25 P/Share
|
|
Feb 28
2025
|
Suma Krishnan President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+0.99%
|
-
|
|
Feb 28
2025
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,786
-14.19%
|
$1,035,694
$179.25 P/Share
|
|
Feb 28
2025
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+23.44%
|
-
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
13,885
-0.46%
|
$2,485,415
$179.25 P/Share
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
30,000
+0.99%
|
-
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,985
-0.47%
|
$3,935,315
$179.25 P/Share
|
|
Feb 28
2025
|
Krish S Krishnan President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,500
+1.0%
|
-
|
|
Feb 27
2025
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
750
-5.62%
|
$131,250
$175.22 P/Share
|
|
Feb 26
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Indirect |
4,721
-0.3%
|
$830,896
$176.39 P/Share
|
|
Feb 26
2025
|
Suma Krishnan President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,286
-0.22%
|
$578,336
$176.39 P/Share
|
|
Feb 26
2025
|
Kathryn Romano Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,268
-14.52%
|
$399,168
$176.39 P/Share
|
|
Feb 26
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,286
-0.22%
|
$578,336
$176.39 P/Share
|
|
Feb 26
2025
|
Krish S Krishnan President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,721
-0.31%
|
$830,896
$176.39 P/Share
|